Varespladib: targeting the inflammatory face of atherosclerosis
- PMID: 21112895
- DOI: 10.1093/eurheartj/ehq385
Varespladib: targeting the inflammatory face of atherosclerosis
Comment on
-
Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease.Eur Heart J. 2011 Apr;32(8):999-1005. doi: 10.1093/eurheartj/ehq374. Epub 2010 Nov 16. Eur Heart J. 2011. PMID: 21081550 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical